Literature DB >> 18243730

Germinal center structure and function: lessons from CD19.

Robert H Carter1, Riley Myers.   

Abstract

The germinal center is a critical locus in the production of protective immunity, but its function is poorly understood. Studies of mutant forms of CD19 revealed differences in signaling in different compartments inside the germinal center, and structural findings indicate a selective role in the interaction with follicular dendritic cells in the GC. Loss of these signals leads to surprising changes in germinal center B cells that challenge previous models of GC function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18243730      PMCID: PMC2346595          DOI: 10.1016/j.smim.2007.12.007

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  36 in total

Review 1.  Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex.

Authors:  D T Fearon; M C Carroll
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification.

Authors:  M Fujimoto; Y Fujimoto; J C Poe; P J Jansen; C A Lowell; A L DeFranco; T F Tedder
Journal:  Immunity       Date:  2000-07       Impact factor: 31.745

3.  CD19-deficient mice exhibit poor responsiveness to oral immunization despite evidence of unaltered total IgA levels, germinal centers and IgA-isotype switching in Peyer's patches.

Authors:  E Gärdby; N Y Lycke
Journal:  Eur J Immunol       Date:  2000-07       Impact factor: 5.532

4.  Cutting edge: germinal centers can be induced in the absence of T cells.

Authors:  V M Lentz; T Manser
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

5.  The physiologic role of CD19 cytoplasmic tyrosines.

Authors:  Yue Wang; Stephen R Brooks; Xiaoli Li; Amy N Anzelon; Robert C Rickert; Robert H Carter
Journal:  Immunity       Date:  2002-10       Impact factor: 31.745

Review 6.  Signaling by the CD19/CD21 complex on B cells.

Authors:  Robert H Carter; Robert A Barrington
Journal:  Curr Dir Autoimmun       Date:  2004

7.  Systematic analysis of the role of CD19 cytoplasmic tyrosines in enhancement of activation in Daudi human B cells: clustering of phospholipase C and Vav and of Grb2 and Sos with different CD19 tyrosines.

Authors:  S R Brooks; X Li; E J Volanakis; R H Carter
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

Review 8.  Germinal-center organization and cellular dynamics.

Authors:  Christopher D C Allen; Takaharu Okada; Jason G Cyster
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

Review 9.  Reassessing the function of immune-complex retention by follicular dendritic cells.

Authors:  Ann M Haberman; Mark J Shlomchik
Journal:  Nat Rev Immunol       Date:  2003-09       Impact factor: 53.106

10.  Very low affinity B cells form germinal centers, become memory B cells, and participate in secondary immune responses when higher affinity competition is reduced.

Authors:  Joseph M Dal Porto; Ann M Haberman; Garnett Kelsoe; Mark J Shlomchik
Journal:  J Exp Med       Date:  2002-05-06       Impact factor: 14.307

View more
  18 in total

Review 1.  Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.

Authors:  Martin F Bachmann; Gary T Jennings
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

2.  Growth-factor receptor-bound protein-2 (Grb2) signaling in B cells controls lymphoid follicle organization and germinal center reaction.

Authors:  Ihn Kyung Jang; Darran G Cronshaw; Luo-kun Xie; Guoqiang Fang; Jinping Zhang; Hyunju Oh; Yang-Xin Fu; Hua Gu; Yongrui Zou
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-20       Impact factor: 11.205

3.  Phase I multidose-escalation study of the anti-CD19 maytansinoid immunoconjugate SAR3419 administered by intravenous infusion every 3 weeks to patients with relapsed/refractory B-cell lymphoma.

Authors:  Anas Younes; Stella Kim; Jorge Romaguera; Amanda Copeland; Silvana de Castro Farial; Larry W Kwak; Luis Fayad; Frederick Hagemeister; Michelle Fanale; Sattva Neelapu; John M Lambert; Rodica Morariu-Zamfir; Sandrine Payrard; Leo I Gordon
Journal:  J Clin Oncol       Date:  2012-07-02       Impact factor: 44.544

Review 4.  Pathological role of tonsillar B cells in IgA nephropathy.

Authors:  Yusuke Suzuki; Hitoshi Suzuki; Junichiro Nakata; Daisuke Sato; Tadahiro Kajiyama; Tomonari Watanabe; Yasuhiko Tomino
Journal:  Clin Dev Immunol       Date:  2011-07-18

5.  AID-targeting and hypermutation of non-immunoglobulin genes does not correlate with proximity to immunoglobulin genes in germinal center B cells.

Authors:  Hillary Selle Gramlich; Tara Reisbig; David G Schatz
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

Review 6.  Targeting CD19 in B-cell lymphoma: emerging role of SAR3419.

Authors:  Ali Raufi; Abdul Shukkur Ebrahim; Ayad Al-Katib
Journal:  Cancer Manag Res       Date:  2013-08-27       Impact factor: 3.989

Review 7.  New antibody approaches to lymphoma therapy.

Authors:  Tejas Suresh; Lisa X Lee; Jitesh Joshi; Stefan K Barta
Journal:  J Hematol Oncol       Date:  2014-09-09       Impact factor: 17.388

8.  γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay.

Authors:  Ursula Jördis Eva Seidel; Fabian Vogt; Ludger Grosse-Hovest; Gundram Jung; Rupert Handgretinger; Peter Lang
Journal:  Front Immunol       Date:  2014-12-02       Impact factor: 7.561

9.  Enhanced susceptibility to Citrobacter rodentium infection in microRNA-155-deficient mice.

Authors:  Simon Clare; Victoria John; Alan W Walker; Jennifer L Hill; Cei Abreu-Goodger; Christine Hale; David Goulding; Trevor D Lawley; Pietro Mastroeni; Gadi Frankel; Anton J Enright; Elena Vigorito; Gordon Dougan
Journal:  Infect Immun       Date:  2012-12-21       Impact factor: 3.441

Review 10.  Blinatumomab: a bispecific T cell engager (BiTE) antibody against CD19/CD3 for refractory acute lymphoid leukemia.

Authors:  Jingjing Wu; Jiaping Fu; Mingzhi Zhang; Delong Liu
Journal:  J Hematol Oncol       Date:  2015-09-04       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.